AORT (Artivion) Forward Dividend Yield %: 0.00% (As of Jun. 26, 2026)


AORT Artivion Inc AORT
81 GF Score
Price $23.62
GF Value $28.37
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Artivion Forward Dividend Yield %?

Artivion AORT +4.25% 81 Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.37 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Artivion ranks worse than 316455.38% on this metric.

As of today (2026-06-26), the Forward Annual Dividend Yield of Artivion is 0.00%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of Artivion is 0.00%.

AORT's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09
* Ranked among companies with meaningful Forward Dividend Yield % only.

Artivion's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Artivion was 33.90% per year. The lowest was 33.90% per year. And the median was 33.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Artivion  (NYSE:AORT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Artivion Forward Dividend Yield % Related Terms


AORT vs CNMD, AVNS, IRMD: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Artivion's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artivion Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Artivion's Forward Dividend Yield % falls into.


AORT
81GF Score
Artivion Inc AORT
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artivion Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Artivion (AORT) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Artivion and its competitors. According to the industry distribution chart, Artivion ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Artivion's Forward Dividend Yield % too high?
Artivion's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Artivion ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's Forward Dividend Yield % compare to CNMD and AVNS?
According to the Medical Devices & Instruments industry distribution chart, Artivion ranks #999999 out of 316 companies for Forward Dividend Yield %. This places Artivion in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Artivion and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artivion's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.37, compared to a current price of $23.62 — trading 16.7% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Artivion (AORT), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Artivion (AORT) Overvalued in 2026?

Based on GuruFocus' analysis, Artivion stock appears to be undervalued. The current stock price of $23.62 is trading 16.7% below its estimated GF Value™ of $28.37. GuruFocus considers Artivion to be Modestly Undervalued.

Key valuation signals for AORT:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: $28.37 vs. price of $23.62 (16.7% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Artivion Business Description

Other Exchanges CYL:Germany
Address 1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score

Get the complete analysis for AORT

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.62
Price
$28.37
GF Value